MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, announced that it will host a virtual Key Opinion Leader (KOL) event on locally advanced pancreatic cancer on Friday, October 2, 2020, at 11 a.m. EDT.
Sarah Hoffe, M.D., will provide a review of the management of patients with localized pancreatic cancer, including the current clinical treatment paradigm and the use of stereotactic body radiation therapy (SBRT). Dr. Hoffe is the Section Head of GI Radiation Oncology and Senior Member at Moffitt Cancer Center.
The live audio webcast of the event will be accessible from the Investors page of Galera’s website, investors.galeratx.com. Individuals can participate in an interactive Q&A session by submitting pertinent questions via the webcast platform.
An archived version of the webcast will be available in the News & Events section of the Investors page of Galera’s website for 60 days following the event.
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.